Evidence map›Paper›PMID 36291964›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Lung Radiomics Features Selection for COPD Stage Classification Based on Auto-Metric Graph Neural Network.

Yingjian Yang, Shicong Wang, Nanrong Zeng, Wenxin Duan, Ziran Chen, Yang Liu, Wei Li, Yingwei Guo, Huai Chen, Xian Li and 2 more

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. A CT-Based Lung Radiomics Nomogram for Classifying the Severity of Chronic Obstructive Pulmonary Disease.International journal of chronic obstructive pulmonary disease · 2024
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yingjian YangCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang 110169, China.ORCID 0000-0002-7425-1297
Shicong WangCollege of Health Science and Environmental Engineering, Shenzhen Technology University, Shenzhen 518118, China.
Nanrong ZengCollege of Health Science and Environmental Engineering, Shenzhen Technology University, Shenzhen 518118, China.
Wenxin DuanCollege of Health Science and Environmental Engineering, Shenzhen Technology University, Shenzhen 518118, China.
Ziran ChenCollege of Health Science and Environmental Engineering, Shenzhen Technology University, Shenzhen 518118, China.
Yang LiuCollege of Health Science and Environmental Engineering, Shenzhen Technology University, Shenzhen 518118, China.
Wei LiCollege of Health Science and Environmental Engineering, Shenzhen Technology University, Shenzhen 518118, China.
Yingwei GuoCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang 110169, China.ORCID 0000-0002-3049-8474
Huai ChenDepartment of Radiology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Xian LiDepartment of Radiology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Rongchang ChenShenzhen Institute of Respiratory Diseases, Shenzhen People's Hospital, Shenzhen 518001, China.
Yan KangCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang 110169, China.ORCID 0000-0002-4532-5744

Funding

the National Natural Science Foundation of China 62071311the Natural Science Foundation of Guangdong Province of China 2019A1515011382the Scientific Research Fund of Liaoning Province of China JL201919the special program for key fields of colleges and universities in Guangdong Province (biomed-icine and health) of China 2021ZDZX2008the Stable Support Plan for Colleges and Universities in Shenzhen of China SZWD2021010
6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is a preventable, treatable, progressive chronic disease characterized by persistent airflow limitation. Patients with COPD deserve special consideration regarding treatment in this fragile population for preclinical health management. Therefore, this paper proposes a novel lung radiomics combination vector generated by a generalized linear model (GLM) and Lasso algorithm for COPD stage classification based on an auto-metric graph neural network (AMGNN) with a meta-learning strategy. Firstly, the parenchyma images were segmented from chest high-resolution computed tomography (HRCT) images by ResU-Net. Second, lung radiomics features are extracted from the parenchyma images by PyRadiomics. Third, a novel lung radiomics combination vector (3 + 106) is constructed by the GLM and Lasso algorithm for determining the radiomics risk factors (K = 3) and radiomics node features (d = 106). Last, the COPD stage is classified based on the AMGNN. The results show that compared with the convolutional neural networks and machine learning models, the AMGNN based on constructed novel lung radiomics combination vector performs best, achieving an accuracy of 0.943, precision of 0.946, recall of 0.943, F1-score of 0.943, and ACU of 0.984. Furthermore, it is found that our method is effective for COPD stage classification.

Indexed as

auto-metric graph neural network (AMGNN)chest HRCT imageCOPD stage (GOLD)generalized linear model (GLM)Lasso algorithmlung radiomics featuresmulti-classification

Identifiers

PMID36291964
PMCPMC9600898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.